Sponsored content

Peter Brownlow and Mark Hilton of Bird & Bird consider the impact of Brexit on international IP cases heard in England

Manisha Singh and Simran Bhullar of LexOrbis take a look at the surprising court record of a persistent offender deceptively targeting Indian health and beauty brands

Min Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies

Takanori Abe of Abe & Partners previews potential suggested changes to Japan’s patent world

Eva Ehlich, Angela Zumstein and James Neuhaus of Maiwald note their observations on oral proceedings before the Enlarged Board of Appeal

Barış Kalaycı and Direnç Bada of Gün and Partners assess the benefits of filing a criminal case based on trademark infringement for counterfeit products subject to the crime of smuggling

Ranjan Narula of RNA, Technology and IP Attorneys takes a look at the new due diligence mechanism and considers why this has caused a backlash

Vladimir Biriulin of Gorodissky & Partners looks at why IP owners in Russia are increasingly satisfied with the outcome of disputes

Kene Gallois and Guilherme Coutinho of Daniel Law explain how the success of the plan will pave the way for Brazil to attract further investment and opportunities

The combination will accelerate tech innovation and provide a stronger, more united voice to help drive positive change in the online environment

Gang Hu of CCPIT Patent and Trademark Law Office discusses the Economic and Trade Agreement between China and the US regarding the protection of geographical indications

Manisha Singh and Pankaj Musyuni of LexOrbis discuss regulatory changes for medical device companies and the impact of COVID-19 on manufacturers